Yahoo!'s (NASDAQ: YHOO) Project Panama is the web giant's attempt to re-thread its entire text-based advertising system to emulate Google's AdWords system. Google's system lets advertisers compete on customer relevancy and click-through rather than on advertised keyword bid price. Obviously, Google's relevancy model is the clear winner here, after Yahoo!, which spent over a billion smackers to buy Overture years ago, has admitted that keyword bidding just doesn't work as as well -- the customers (not the advertisers) have to be in charge.
Yahoo!'s new text advertising system went live in the U.S. during the last calendar quarter of 2006 and is looming on the horizon to be launched in the UK (and other markets) soon. Yahoo! still receives quite a bit of traffic to its network (search not so much) and wants to monetize more of that with advertising methods that actually work well. Hence, Project Panama. Should Google be scared that it may now have heightened competition in the web search space? Not unless Yahoo! can grab market share away from Google in web search, which I do not see happening. But, Yahoo! will glow a little brighter, which is the injection of life the company needs right now.
Yahoo! recently told its UK advertising partners to get ready for Panama: "Our new Sponsored Search system will be rolled out in the UK soon, beginning with advertiser migration later this quarter. We will be contacting you with more specific information as the rollout date approaches." Will this be enough to get Yahoo! into some kind of spotlight again with customers? Yahoo! CEO Terry Semel has said many times recently that Project Panama is "doing very well" in the U.S., but he has not given much on specifics, yet. At some near-future time, YHOO shareholders are going to want to know all about this. It won't be Yahoo!'s curtain call if it does not perform that well, but the added pressure may give even more employees a reason to flee.
Last updated: February 13, 2012: 04:48 AM
Hot Stocks
DailyFinance Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
Benzinga Headlines
- Michigan Consumer Sentiment Index Drops
- Don't Bank on Barclays
- GSV Capital Punished for Expanding Facebook Investment
- Chesapeake Gently Lets Go of Gas
- How to Profit off Addicts
TheFlyOnTheWall.com Headlines
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger

